I’ve been working in the research chemical scene for some time now and over time I’ve ingested many, many substances to extrapolate their effects. This is all research to determine the Research chemicals between different compounds. Basically what compounds hit which receptors and what happens next. On my own journey I’ve been as far as one could go in terms of “highness”!
Though the research chemical scene today is dwindling. It’s still producing many novel compounds to bypass laws only in the most popular areas, which are most often the empathogens, stimulants and cannabinoids. We have now 5-EAPB, a-PVP, MPA and numerous cannabinoids which seem to pop up faster than you can also fully understand the last. My favourites in the cannabinoids need to be the cannabinoid re-uptake inhibitors including LY-2183240. These compounds don’t actually agonise your cannabinoid receptors as Cannabis and other cannabinoids do but they enhance your own endogenous cannabinoids, so essentially you’re getting high off your own juices! Then when they are put together with agonists for example THC or other synthetic cannabinoids, they increase the high to such an extent that a gram of weed could endure every week with say 20mg from the CRI’s! Since is innovation.
I’m not here to speak with you about Dibutylone though. Exactly what is really on my own agenda is the possible lack of innovation inside the psychedelic realm. PIHKAL and TIHKAL have offered us a huge selection of compounds that may be made yet only the standard are marketed. Now to me this really is a problem. I love novel psychedelics. In fact I really could name some that we composed here and today (i.e. 2C-MAL, 4-Bromo-Mescaline, 4-PropO-PiPT etc.).
The very fact in the matter is the fact no-one is producing novel psychedelics anymore. There were several within the last few years that had been great including 3C-E and bk-2C-B but in addition to those (rather meagre) psychedelics, there has been no big bangs, which happens to be what I love. The compounds that may be a major hit are: 5-TOET, ALEPH & ALEPH-2, 2C-EF, 2C-TFM, CPM, 2C-T-21, DMMDA, psi-DOx (these have lowered duration for individuals who aren’t fans of long psychedelics), MEM, MMDA-2, MMDA-3a (and it’s methyl analogue), MMDA itself (capable of producing ‘brain movies’) as well as a whole host of other analogues for example 2C-C-FLY.
We have to provide praise for some that are producing such compounds though as DON, DOET, LSZ, AL-LAD and 2C-B-FLY make it on the scene recently.
However my main message in this particular is as darknets are expanding, the necessity for analogues and research chemicals has become redundant. People would prefer to obtain a gram of MDMA than the usual gram of ethyl-hexedrone. They’d rather get some 2C-B than some 2C-T-16 or 2C-YN. The investigation chemical scene was once thriving and everybody wanted to make their 87dexlpky in the world. Just examine how good MXE has been doing, and this may not be even near what is. With some imagination and drive, better still compounds could possibly be created. They should also be distributed at the retail end because there are many wholesalers that do produce fantastic products but consumers are so dead set on which they know and want there is no room for expansion.
Once we are to evolve chemically we have to learn to abandon the fundamental drugs we all know and love. It’s a risky venture, needless to say, but those that use drugs take part in risky behaviour at all times, why not expand those boundaries to allow in a number of the fantastic compounds which can be around waiting to be synthesized? This is certainly evolution at it’s most straightforward definition with the introduction of Black Marketplaces it seems like we are at a lull, we have been not striving for the future but perhaps, someday, we’ll wake up and realise how the compounds many have neglected are those which they want by far the most.